ライフサイエンスコーパス: posttraumatic

1 of ICU admission was found as performant as posttraumatic amnesia (area under the curve, 0.81; diffe

2 at ICU admission (phase 1) and compared with posttraumatic amnesia duration and the initial Glasgow C

3 s of ICU admission could be as performant as posttraumatic amnesia for predicting traumatic brain inj

4 Posttraumatic amnesia is superior to the initial Glasgow

5 ble methods of secondary IOL implantation in posttraumatic and postoperative aphakia.

6 tureless Sharioth technique in patients with posttraumatic and postoperative aphakia.

7 activator (uPA) from injured brain leads to posttraumatic bleeding by causing premature clot lysis.

8 The development of posttraumatic brain edema can limit the oxygen utilizati

9 ence supporting a potential relation between posttraumatic brain hypoxia and microcirculatory derange

10 waking brain, and is slowed in the aging and posttraumatic brain.

11 xiety, panic, phobia, obsession, compulsion, posttraumatic, care management, case management, collabo

12 e of Coping Status-A), posttraumatic stress (Posttraumatic Checklist-Specific Stressor), anxiety (Hos

13 Self-reported PTSD symptoms and posttraumatic cognitions were secondary outcomes.

14 irst discuss trauma to the temporal bone and posttraumatic complications.

15 erapy significantly predicted improvement in Posttraumatic Diagnostic Scale scores (beta = -3.86 [95%

16 OP arm had significantly larger decreases in Posttraumatic Diagnostic Scale scores (from 35.0 to 29.1

17 m also had significantly larger decreases in Posttraumatic Diagnostic Scale scores (from 35.0 to 30.1

18 outcome was PTSD severity as measured by the Posttraumatic Diagnostic Scale.

19 rify the relationship between resilience and posttraumatic growth.

20 An important trigger of the posttraumatic immune response is the complement anaphyla

21 ism induced by injury to reduce the risk for posttraumatic infection.

22 Treating posttraumatic lower extremity wounds can be challenging,

23 with mild traumatic brain injury (mTBI) with posttraumatic migraines (PTMs) and those without PTMs on

24 tter injury patterns were seen for two major posttraumatic neuropsychiatric symptoms.

25 wn determinant for subsequent development of posttraumatic OA, which accounts for 12% of all OA.

26 le therapy for reducing cartilage injury and posttraumatic osteoarthritis by attenuating Piezo-mediat

27 We used a murine model of acute, posttraumatic osteomyelitis to evaluate the virulence of

28 omplex regional pain syndrome (CRPS), a rare posttraumatic pain condition.

29 Posttraumatic patients should be kept under medical obse

30 (234/5153) were designated as feline ocular posttraumatic sarcoma, a tumor previously demonstrated t

31 re also significant differences in scores of posttraumatic stress (AMD, -5.86; 95% CI, -8.53 to -3.19

32 y Adjustment Schedule [WHODAS]), symptoms of posttraumatic stress (measured by the Posttraumatic Stre

33 vised), coping (Measure of Coping Status-A), posttraumatic stress (Posttraumatic Checklist-Specific S

34 gnificant levels of depression, anxiety, and posttraumatic stress among patients and levels of burden

35 tween deployment-acquired TBI and subsequent posttraumatic stress and related disorders among U.S. Ar

36 ttle is understood about how the symptoms of posttraumatic stress develop over time into the syndrome

37 roup analysis revealed a lower prevalence of posttraumatic stress disorder (odds ratio, 0.23; 95% CI,

38 02), bipolar I (OR, 1.5; 95% CI, 1.06-2.05), posttraumatic stress disorder (OR, 1.6; 95% CI, 1.27-2.1

39 ssault-related injury (P<.001), diagnosis of posttraumatic stress disorder (P=.008), and diagnosis of

40 earlier trauma exposure is known to predict posttraumatic stress disorder (PTSD) after subsequent tr

41 f exposure to stressful experiences, such as posttraumatic stress disorder (PTSD) and depression, are

42 an drive neuropsychiatric disorders, such as posttraumatic stress disorder (PTSD) and drug addiction.

43 ales disproportionately have higher rates of posttraumatic stress disorder (PTSD) and experience grea

44 tress reactivity is a predominant feature of posttraumatic stress disorder (PTSD) and may reflect dis

45 anding the neural causes and consequences of posttraumatic stress disorder (PTSD) and mild traumatic

46 ticipants (N=558) were assessed for probable posttraumatic stress disorder (PTSD) and probable depres

47 ticipants (N=558) were assessed for probable posttraumatic stress disorder (PTSD) and probable depres

48 Posttraumatic stress disorder (PTSD) appears to increase

49 s), obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD) are common mental d

50 Patients with posttraumatic stress disorder (PTSD) are hyperresponsive

51 tudies have found that those who suffer from posttraumatic stress disorder (PTSD) are more likely to

52 d was a significant risk for a high level of posttraumatic stress disorder (PTSD) arousal symptoms.

53 We prospectively examined posttraumatic stress disorder (PTSD) as a long-term cons

54 Posttraumatic stress disorder (PTSD) co-occurs with subs

55 e resilient to psychiatric disorders such as posttraumatic stress disorder (PTSD) compared with those

56 Posttraumatic stress disorder (PTSD) has been associated

57 atic brain injury (TBI) is a risk factor for posttraumatic stress disorder (PTSD) has been difficult

58 The limited neurobiological understanding of posttraumatic stress disorder (PTSD) has been partially

59 Posttraumatic stress disorder (PTSD) has been shown to b

60 ncreasing predictability of animal models of posttraumatic stress disorder (PTSD) has required active

61 ifferential effects of maternal and paternal posttraumatic stress disorder (PTSD) have been observed

62 or (alpha1AR) antagonist prazosin for combat posttraumatic stress disorder (PTSD) in 67 active duty s

63 lable from medical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of t

64 the neurobiological mechanisms that predict posttraumatic stress disorder (PTSD) in recent trauma su

65 re to stress is a risk factor for developing posttraumatic stress disorder (PTSD) in response to trau

66 al blood during the onset and development of posttraumatic stress disorder (PTSD) indicate widespread

67 Posttraumatic stress disorder (PTSD) is a common psychia

68 Posttraumatic stress disorder (PTSD) is a common psychia

69 Posttraumatic stress disorder (PTSD) is a common, debili

70 Posttraumatic stress disorder (PTSD) is a common, freque

71 Posttraumatic stress disorder (PTSD) is a debilitating d

72 Posttraumatic stress disorder (PTSD) is a debilitating p

73 Posttraumatic stress disorder (PTSD) is a disabling psyc

74 Posttraumatic stress disorder (PTSD) is a frequent anxie

75 Posttraumatic stress disorder (PTSD) is a heterogeneous

76 Posttraumatic stress disorder (PTSD) is a prevalent and

77 Posttraumatic stress disorder (PTSD) is a prevalent, ser

78 Posttraumatic stress disorder (PTSD) is a psychiatric il

79 Posttraumatic stress disorder (PTSD) is a relatively com

80 Posttraumatic stress disorder (PTSD) is a severe anxiety

81 Posttraumatic stress disorder (PTSD) is a stress-related

82 Posttraumatic stress disorder (PTSD) is associated with

83 Posttraumatic stress disorder (PTSD) is associated with

84 Posttraumatic stress disorder (PTSD) is both a prevalent

85 econsolidation marker.SIGNIFICANCE STATEMENT Posttraumatic stress disorder (PTSD) is characterized by

86 Posttraumatic stress disorder (PTSD) is considered a dis

87 In the aftermath of a disaster, the risk of posttraumatic stress disorder (PTSD) is high.

88 The development of posttraumatic stress disorder (PTSD) is influenced by ge

89 Posttraumatic stress disorder (PTSD) is linked to elevat

90 Posttraumatic stress disorder (PTSD) is prevalent, persi

91 Although posttraumatic stress disorder (PTSD) is well studied amo

92 Posttraumatic stress disorder (PTSD) may contribute to h

93 ly described the paradoxical co-existence in posttraumatic stress disorder (PTSD) of sensory intrusiv

94 interactions between smoking and symptoms of posttraumatic stress disorder (PTSD) on pain intensity,

95 Medication and psychotherapy treatments for posttraumatic stress disorder (PTSD) provide insufficien

96 The neural substrates of pediatric posttraumatic stress disorder (PTSD) remain incompletely

97 nced trauma and associated distress-that is, posttraumatic stress disorder (PTSD) severity-more than

98 Studies on posttraumatic stress disorder (PTSD) showing attentional

99 The efficacy of posttraumatic stress disorder (PTSD) treatments in psych

100 theater veterans with a high probability of posttraumatic stress disorder (PTSD) were nearly 2 times

101 s process a potential therapeutic target for posttraumatic stress disorder (PTSD), a mental illness c

102 of NPY with trauma-evoked syndromes such as posttraumatic stress disorder (PTSD), although the exact

103 Hippocampus atrophy is implicated in posttraumatic stress disorder (PTSD), and may partly ref

104 ent among veterans, especially veterans with posttraumatic stress disorder (PTSD), and poses a major

105 sychiatric disorders, such as depression and posttraumatic stress disorder (PTSD), are inadequate.

106 posure therapy is an effective treatment for posttraumatic stress disorder (PTSD), but a comprehensiv

107 smaller hippocampal and amygdala volumes in posttraumatic stress disorder (PTSD), but findings have

108 posure therapy is an effective treatment for posttraumatic stress disorder (PTSD), but many patients

109 to underlie the pathophysiology of pediatric posttraumatic stress disorder (PTSD), but the few studie

110 al patterns of spontaneous brain activity in posttraumatic stress disorder (PTSD), but the findings a

111 r (GR) sensitivity is present in people with posttraumatic stress disorder (PTSD), but the molecular

112 n array of pathological conditions including posttraumatic stress disorder (PTSD), characterized by d

113 d C-reactive protein, have been described in posttraumatic stress disorder (PTSD), generalized anxiet

114 erapy (CPT), an evidence-based treatment for posttraumatic stress disorder (PTSD), has not been teste

115 e genetic basis of three disorder categories-posttraumatic stress disorder (PTSD), major depressive d

116 est were 30-day prevalence postdeployment of posttraumatic stress disorder (PTSD), major depressive e

117 eneralization of fear, a cardinal feature of posttraumatic stress disorder (PTSD), manifests as inapp

118 re-based therapy, an effective treatment for posttraumatic stress disorder (PTSD), relies on extincti

119 In about 30-50% of patients with posttraumatic stress disorder (PTSD), symptoms persist a

120 factor for cardiovascular disease (CVD), and posttraumatic stress disorder (PTSD), the sentinel stres

121 for developing anxiety disorders, including posttraumatic stress disorder (PTSD), the underlying mec

122 Posttraumatic stress disorder (PTSD), while highly preva

123 tion to threat is perturbed in patients with posttraumatic stress disorder (PTSD), with some studies

124 Posttraumatic stress disorder (PTSD)-a chronic, debilita

125 g in the formation of indelible memories and posttraumatic stress disorder (PTSD).

126 identified a role of leaky neuronal RyR2 in posttraumatic stress disorder (PTSD).

127 tric disorders, and is a defining feature of posttraumatic stress disorder (PTSD).

128 f quetiapine monotherapy in the treatment of posttraumatic stress disorder (PTSD).

129 s modulatory transmitter, is associated with posttraumatic stress disorder (PTSD).

130 nimal model of traumatic memory formation in posttraumatic stress disorder (PTSD).

131 n considered imperative in psychotherapy for posttraumatic stress disorder (PTSD).

132 onfer an increased incidence and severity of posttraumatic stress disorder (PTSD).

133 ce to existing evidence-based treatments for posttraumatic stress disorder (PTSD).

134 stress during a traumatic event may lead to posttraumatic stress disorder (PTSD).

135 e variability (HRV) has been associated with posttraumatic stress disorder (PTSD).

136 d its dysfunction potentially contributes to posttraumatic stress disorder (PTSD).

137 extinction learning are believed to sustain posttraumatic stress disorder (PTSD).

138 tress develop over time into the syndrome of posttraumatic stress disorder (PTSD).

139 otein (CRP) are elevated in individuals with posttraumatic stress disorder (PTSD).

140 tor for later life anxiety disorders such as posttraumatic stress disorder (PTSD).

141 y few preventive interventions available for posttraumatic stress disorder (PTSD).

142 insufficient to reduce the burden of chronic posttraumatic stress disorder (PTSD).

143 ences, including their propensity to develop posttraumatic stress disorder (PTSD).

144 is widely accepted as a pathogenic marker of posttraumatic stress disorder (PTSD).

145 ala reactivity is a vulnerability factor for posttraumatic stress disorder (PTSD); however, our under

146 disorder (RR, 1.29 [95% CI, 1.01-1.65]), and posttraumatic stress disorder (RR, 1.47 [95% CI, 1.09-1.

147 hose who screened positive for depression or posttraumatic stress disorder after return from deployme

148 New possibilities for treating posttraumatic stress disorder and anxiety disorders invo

149 pite significant overlap of symptoms between posttraumatic stress disorder and anxiety disorders, the

150 thasone compared with placebo on symptoms of posttraumatic stress disorder and depression and health-

151 nts, beneficial effects on the occurrence of posttraumatic stress disorder and depression may be pres

152 Posttraumatic stress disorder and depression were presen

153 nea and insomnia), mental health status (eg, posttraumatic stress disorder and depression), nonocular

154 seases; and mental health disorders, such as posttraumatic stress disorder and depression, that are a

155 e blast TBI was also observed on measures of posttraumatic stress disorder and depression.

156 stoperative admission to the ICU may lead to posttraumatic stress disorder and depression.

157 ively or negatively affect the prevalence of posttraumatic stress disorder and depression.

158 or the treatment of mental disorders such as posttraumatic stress disorder and drug addiction.

159 es in connectivity in patients with comorbid posttraumatic stress disorder and MDD.

160 a burden to daily life and characteristic of posttraumatic stress disorder and other anxiety disorder

161 responses and have been have been linked to posttraumatic stress disorder and other mental health af

162 le target in developing novel treatments for posttraumatic stress disorder and related disorders.

163 s potential therapeutic effects for treating posttraumatic stress disorder are related to altering em

164 ew Version (PSS-I) and the stressor-specific Posttraumatic Stress Disorder Checklist (PCL-S); seconda

165 oms of posttraumatic stress (measured by the Posttraumatic Stress Disorder Checklist [PCL]), personal

166 outcomes were posttraumatic stress symptoms (Posttraumatic Stress Disorder Checklist for DSM-5), func

167 y the Neurobehavioral Symptom Inventory, the Posttraumatic Stress Disorder Checklist Military Version

168 onnaire) and post-traumatic stress symptoms (Posttraumatic Stress Disorder Checklist).

169 ses including mild traumatic brain injury or posttraumatic stress disorder display alterations on ASL

170 Secondary outcomes included posttraumatic stress disorder experienced by the family

171 conversely, to the potential development of posttraumatic stress disorder following trauma.

172 The Psychiatric Genomics Consortium-Posttraumatic Stress Disorder group (PGC-PTSD) combined

173 co-occurring psychiatric conditions and with posttraumatic stress disorder having the largest impact.

174 polymorphism, rs4523957, is associated with posttraumatic stress disorder in humans, consistent with

175 that PACAP dysregulation is associated with posttraumatic stress disorder in humans.

176 health, increasing depression, anxiety, and posttraumatic stress disorder in these same villages.

177 he Impact of Event Scale was the most common posttraumatic stress disorder instrument.

178 Posttraumatic stress disorder is often comorbid with MDD

179 Posttraumatic stress disorder manifests after exposure t

180 nisms of severe sepsis in the development of posttraumatic stress disorder need further examination.

181 There has been relatively little study of posttraumatic stress disorder or obsessive-compulsive di

182 lthough pathological fear, such as occurs in posttraumatic stress disorder or specific phobias, is al

183 ntify anxiety, stress, caregiver burden, and posttraumatic stress disorder outcomes in informal careg

184 of threat.SIGNIFICANCE STATEMENT Anxiety and posttraumatic stress disorder patients generalize fear t

185 sing a locally validated version of the UCLA Posttraumatic Stress Disorder Reaction Index (range, 0-4

186 (OR, 1.15; 95% CI, 1.02-1.30; P = .02), and posttraumatic stress disorder score (OR, 1.04; 95% CI, 1

187 fied between overall DE symptom severity and posttraumatic stress disorder scores and tear breakup ti

188 ation manual was associated with significant posttraumatic stress disorder symptom reduction at 2 mon

189 e pooled prevalences of clinically important posttraumatic stress disorder symptoms (95% CI) were 25%

190 ationship to whole-brain cortical thickness, posttraumatic stress disorder symptoms (PTSD) and depres

191 turned out to be a significant predictor of posttraumatic stress disorder symptoms at 3-month follow

192 atients with general anxiety, depression, or posttraumatic stress disorder symptoms during 2-year fol

193 lihood of remission from general anxiety and posttraumatic stress disorder symptoms during follow-up.

194 e individuals, increased lifetime stress and posttraumatic stress disorder symptoms explained the maj

195 ICU risk factors for posttraumatic stress disorder symptoms included benzodia

196 Clinically important posttraumatic stress disorder symptoms occurred in one f

197 rathreshold general anxiety, depression, and posttraumatic stress disorder symptoms ranged from 38% t

198 ore was 17 (9-24), and pooled prevalences of posttraumatic stress disorder symptoms were 17% (10-26%)

199 Posttraumatic stress disorder symptoms were associated w

200 Posttraumatic stress disorder symptoms were higher in th

201 vised (scores >/= 1.6 indicating substantial posttraumatic stress disorder symptoms).

202 s associated with a significant reduction in posttraumatic stress disorder symptoms, 2) a self-help r

203 significant general anxiety, depression, or posttraumatic stress disorder symptoms, and these sympto

204 r depression symptoms and may have increased posttraumatic stress disorder symptoms.

205 subsequent remission of general anxiety and posttraumatic stress disorder symptoms.

206 urse-led ICU follow-up clinic did not reduce posttraumatic stress disorder symptoms.

207 imultaneous general anxiety, depression, and posttraumatic stress disorder symptoms.

208 In European studies, ICU diaries reduced posttraumatic stress disorder symptoms.

209 tors, but with more obesity, depression, and posttraumatic stress disorder than men.

210 acotherapies and device-based treatments for posttraumatic stress disorder that have been developed v

211 Posttraumatic stress disorder was assessed by the Short

212 Posttraumatic stress disorder was found in 7% of the pat

213 Acute stress disorder and posttraumatic stress disorder were diagnosed according t

214 lthough symptoms of anxiety, depression, and posttraumatic stress disorder were found to be common 1

215 ental Disorders (version IV) Criterion A for posttraumatic stress disorder were interviewed.

216 %, 42%, and 24% for depression, anxiety, and posttraumatic stress disorder) at 6 and 12 months.

217 s (i.e., general anxiety, depression, and/or posttraumatic stress disorder).

218 , 20.2%; generalized anxiety disorder, 7.9%; posttraumatic stress disorder, 9.8%; alcohol dependence,

219 specific psychiatric disorders (depression, posttraumatic stress disorder, addiction, social anxiety

220 pulsive disorder, major depressive disorder, posttraumatic stress disorder, and addiction.

221 chronic symptoms of postconcussive disorder, posttraumatic stress disorder, and depression and for th

222 eported symptoms of postconcussive disorder, posttraumatic stress disorder, and depression were deter

223 ast 6-month generalized anxiety disorder and posttraumatic stress disorder, and past 12-month alcohol

224 tions, such as generalized anxiety disorder, posttraumatic stress disorder, and social anxiety disord

225 Mental disorders (any disorder, mood, posttraumatic stress disorder, anxiety, alcohol use diso

226 Depression, posttraumatic stress disorder, anxiety, suicidal ideatio

227 hopathology (indiscriminate social behavior, posttraumatic stress disorder, attention-deficit/hyperac

228 ive disorders (mean scores >35), followed by posttraumatic stress disorder, borderline personality di

229 ocial outcomes (depression, anxiety, stress, posttraumatic stress disorder, burden, activity restrict

230 Symptoms of posttraumatic stress disorder, depression, and health-re

231 antify the impact of psychiatric conditions (posttraumatic stress disorder, depression, anxiety, and

232 ty disorders, obsessive-compulsive disorder, posttraumatic stress disorder, depressive disorders, bip

233 Intelligence was not associated with posttraumatic stress disorder, eating disorders, and anx

234 younger, have more obesity, depression, and posttraumatic stress disorder, less obstructive coronary

235 y a role in the formation and persistence of posttraumatic stress disorder, of which sleep impairment

236 nalyses used a priori seeds relevant to TMS, posttraumatic stress disorder, or MDD (subgenual anterio

237 suicidal plan, bipolar disorder, psychosis, posttraumatic stress disorder, substance dependence, cur

238 memories underlie anxiety disorders, such as posttraumatic stress disorder, the key neural and molecu

239 h symptom levels of depression, anxiety, and posttraumatic stress disorder, which are strongly associ

240 ium and symptoms of anxiety, depression, and posttraumatic stress disorder.

241 rium and symptoms of anxiety, depression, or posttraumatic stress disorder.

242 vant to spatial memory deficits described in posttraumatic stress disorder.

243 of Event Scale 15 item measuring symptoms of posttraumatic stress disorder.

244 illnesses like major depressive disorder and posttraumatic stress disorder.

245 spatial memory dysfunction in, for example, posttraumatic stress disorder.

246 ychiatric conditions, such as depression and posttraumatic stress disorder.

247 tion regulation in insomnia, depression, and posttraumatic stress disorder.

248 cessing (EMDR) is an effective treatment for posttraumatic stress disorder.

249 ess-related disorders, including anxiety and posttraumatic stress disorder.

250 ric conditions such as anxiety disorders and posttraumatic stress disorder.

251 nt of the patients showed a delayed onset of posttraumatic stress disorder.

252 riencing symptoms commensurate with clinical posttraumatic stress disorder.

253 to psychiatric disorders such as anxiety or posttraumatic stress disorder.

254 on, 33% for an anxiety disorder, and 26% for posttraumatic stress disorder.

255 assess symptoms of acute stress disorder and posttraumatic stress disorder.

256 oraphobia, obsessive-compulsive disorder, or posttraumatic stress disorder.

257 ical populations, with a particular focus on posttraumatic stress disorder.

258 ive disorders including major depression and posttraumatic stress disorder.

259 hods for primary prevention and treatment of posttraumatic stress disorder.

260 onditions such as autism, schizophrenia, and posttraumatic stress disorder.

261 disrupted in psychiatric conditions such as posttraumatic stress disorder.

262 depressant for major depressive disorder and posttraumatic stress disorder.

263 qual to 35, indicating a high probability of posttraumatic stress disorder.

264 nd 78 patients (13.8%) who received placebo (posttraumatic stress disorder: odds ratio, 0.82; 95% CI,

265 yment (depression: OR, 1.4; 95% CI, 1.1-1.9; posttraumatic stress disorder: OR, 2.4; 95% CI, 2.1-2.8)

266 increases in the rates of major depression; posttraumatic stress disorder; other anxiety disorders;

267 erapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders and to evaluate whether a

268 erapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders is unclear.

269 Other conditions represented were psychotic, posttraumatic stress or anxiety, somatoform, neurocognit

270 e to women) were associated with more severe posttraumatic stress responses.

271 equal to 14 (interquartile range, 5-20) and Posttraumatic Stress Scale equal to 22 (interquartile ra

272 tal Anxiety and Depression Scale; p = 0.010, Posttraumatic Stress Scale), resilience (p = 0.012, Hosp

273 he Hospital Anxiety and Depression Scale and Posttraumatic Stress Scale.

274 ange of postdisaster trajectories of chronic posttraumatic stress symptom (PTSS) and depression sympt

275 g strategy use is a significant predictor of posttraumatic stress symptom severity 60 days after hosp

276 relationship between patient death and later posttraumatic stress symptom severity.

277 traumatic and, as a consequence, experience posttraumatic stress symptomatology at clinical levels.

278 Secondary outcomes were posttraumatic stress symptoms (Posttraumatic Stress Diso

279 the Impact of Event Scale-Revised assessing posttraumatic stress symptoms 60 days after hospital dis

280 50, p<0.001) were better predictors of later posttraumatic stress symptoms than coping strategies 5 d

281 d social support, cognitive functioning, and posttraumatic stress symptoms were also assessed using s

282 Cognitive functioning and posttraumatic stress symptoms were both significantly as

283 death were the only noncoping predictors of posttraumatic stress symptoms.

284 Symptoms of posttraumatic stress were associated with negative world

285 hological distress (anxiety, depression, and posttraumatic stress).

286 Rates of clinically significant posttraumatic stress, anxiety, and depressive symptoms w

287 gnificant levels of anxiety, depression, and posttraumatic stress, as well as cognitive function and

288 nosis before transplantation (schizophrenia, posttraumatic stress, major depressive, and bipolar diso

289 cantly different regarding the prevalence of posttraumatic stress-related symptoms (52.3 vs 50%, resp

290 tionnaire and the Impact of Event Scale (for posttraumatic stress-related symptoms) 3 months later.

291 sion subscale scores but not with changes in posttraumatic stress-related symptoms.

292 enting subsequent development of symptoms of posttraumatic stress.

293 ent negative life events, and depressive and posttraumatic-stress-disorder symptom scores with placen

294 ered the Acute Stress Disorder Scale and the Posttraumatic Symptom Scale-10 to assess symptoms of acu

295 Primary measures were scores on the Posttraumatic Symptom Scale-Interview Version (PSS-I) an

296 eficits belong to the most prevalent chronic posttraumatic symptoms, most likely due to diffuse axona

297 dings, we recommend aggressive screening for posttraumatic vasospasm in these patients.

298 We used this treatment modality in posttraumatic wounds that were slow to heal in 3 elderly

299 eared to accelerate healing in each of these posttraumatic wounds.

300 It may be a helpful adjunct in nonhealing posttraumatic wounds.